CytoMed Therapeutics Limited GDTC
Set alert
0.91 USD -0.01 -0.98%
At close · Nov 2
0.90 -0.01 -1.01%
After hours · Nov 2, 4:00 PM ET
0.8551 Day range 0.92
0.723 52-week range 2.20
- YTD
- -32.10%
- 1 year
- -58.65%
- Open
- 0.911
- Prev close
- 0.9188
- Mkt cap
- 10.86M
- Vol
- 47.32K
- Avg vol
- 18.87K
- EPS
- -0.23
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.8551
- High
- 0.92
- Forward P/E
- -15.80
- Beta
- 0.00
- Short ratio
- 7.54
- Inst. own
- 0.04%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.43
- 200-d avg
- 2.06
- 1y target
- 5.00
Analyst view
Consensus: none
Price target (mean) 5.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.03 | -0.03 – -0.03 | 0.00 | 0.0% | 156.00K | 0.0% | 1 |
| Next quarter | -0.03 | -0.03 – -0.03 | 0.00 | 0.0% | 156.00K | 0.0% | 1 |
| Current year | -0.15 | -0.15 – -0.15 | -0.28616 | +47.6% | 571.00K | 0.0% | 1 |
| Next year | -0.17 | -0.17 – -0.17 | -0.15 | -13.3% | 520.00K | -8.9% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 10, 2024 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Jun 11, 2024 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Dec 4, 2023 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Jul 21, 2023 | Benchmark | Initiated | — | Speculative Buy |